Article Data

  • Views 2576
  • Dowloads 144

Case Reports

Open Access

Case series of uterine smooth muscle tumors of uncertain malignant potential (STUMP)

  • J. H. Sang1
  • J. I. Choi1
  • S.-H. Chung1,*,

1Department of Obstetrics and Gynecology, Soonchunhyang University College of Medicine, Bucheon, Korea

DOI: 10.31083/j.ejgo.2020.03.5306 Vol.41,Issue 3,June 2020 pp.492-494

Submitted: 24 June 2019 Accepted: 09 September 2019

Published: 15 June 2020

*Corresponding Author(s): S.-H. Chung E-mail: guardc@schmc.ac.kr

Abstract

Uterine smooth-muscle tumors of uncertain malignant potential(STUMP) cannot be categorized as benign or malignant. In this paper, the authors describe several cases presenting with STUMP. The authors reported five cases of STUMP treated in Soonchunhyang University Bucheon Hospital from 2013 to 2016. Four patients remain recurrence free (26-60 months) and one patient was lost to follow-up one month after STUMP diagnosis, revisited three years later, and was diagnosed with high-grade (Stage IIa) ovarian serous carcinoma after a staging operation. The authors suggested that regular follow-up after surgery was important in STUMP, and more aggressive surgical management, including salpingo-oophorectomy, should be considered.

Keywords

Leiomyoma; Smooth muscle tumor; Uterine neoplasms

Cite and Share

J. H. Sang, J. I. Choi,S.-H. Chung. Case series of uterine smooth muscle tumors of uncertain malignant potential (STUMP). European Journal of Gynaecological Oncology. 2020. 41(3);492-494.

References

[1] Guntupalli S.R., Ramirez P.T., Anderson M.L., Milam M.R., Bodurka D.C., Malpica A.: “Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis”. Gynecol. Oncol., 2009, 113, 324.

[2] Dall’Asta A., Gizzo S., Musaro A., Quaranta M., Noventa M., Migli- avacca C., et al.: “Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence”. Int. J. Clin. Exp. Pathol., 2014, 7, 8136.

[3] Kalogiannidis I., Stavrakis T., Dagklis T., Petousis S., Nikolaidou C., Venizelos I., et al.: “A clinicopathological study of atypical leiomyomas: Benign variant leiomyoma or smooth-muscle tumor of uncertain malignant potential”. Oncol. Lett., 2016, 11, 1425.

[4] Hendrickson M.R., Tavassoli F.A., Kempson R.L., McCluggage W.G., Haller U., Kubik-Huch R.A.: “Mesenchymal tumours and related lesions”. In: Tavassoli F.A., Devilee P., (eds). World Health Or- ganization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon, FR: IARC Press, 2003, 233.

[5] Kempson R.L.: “Sarcomas and related neoplasms”. In: Norris H.J., Hertig A.T., Abell M.R., (eds). The uterus. Baltimore, MD: Williams & Wilkins, 1973, 298.

[6] Taylor H.B., Norris H.J.: “Mesenchymal ,tumors of the uterus. IV. Diagnosis and prognosis of leiomyosarcomas”. Arch. Pathol., 1966, 82, 40.

[7] Bell S.W., Kempson R.L., Hendrickson M.R.: “Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases”. Am. J. Surg. Pathol., 1994, 18, 535.

Submission Turnaround Time

Top